Management of RSV Bronchiolitis in Outpatient Setting

• DOI: 10.1055/a-2380-2878
• Publication Date: 2024-09-20T22:59:35Z
• Authors: Johannes Borgmann; Lea Sandmann; Simon Ritter; Axel Heep; Holger Köster; Martin Wetzke; Matthias Lange
• Keywords: Guideline; Hypertonic saline; Palivizumab; Outpatient visits; Outpatient clinic

Abstract Seasonal respiratory syncytial virus (RSV) lower infections (RSV-LRI) and bronchiolitis in children remain a high burden to medical facilities. Studies evaluating the practical approach outpatient settings are scarce. We conducted survey provide an insight into management pediatric offices Germany. Invitations for participation online were sent 623 providers of primary care via email. Recipients randomly chosen from national databanks based on zip codes. The response rate was 16,2%, n=92 (14,7%) questionnaires fully answered analyzed. 93,5% (n=86) board certified pediatricians. In setting, every second patient with suspected or confirmed RSV-LRI is presented three times more. 40,7% our participants refer less than 10% all patients hospital, 83,7% one third (<30%). 33,7% never perform virological testing cases RSV-LRI. More 50% prescribe bronchodilators, hypertonic saline inhalation prescribed by 17,4%. Antibiotics About 3/4 ask clearer, more conclusive guideline regarding prophylaxis. diagnostic varies significantly. Although not recommended international guidelines, bronchodilators still frequently used. Considering emerging options passive immunization, broader inclusion criteria immunization regimes requested participants. guidelines recommendations could further improve children.